Normolose

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Normolose

What is Normolose?

Normolose is a pharmacological treatment categorized as an osmotic laxative. It is primarily composed of lactulose, a synthetic disaccharide derived from lactose. Unlike nutrients that are absorbed by the small intestine, Normolose remains largely unchanged as it passes into the colon.

Mechanism of Action

Once it reaches the large intestine, the active component in Normolose undergoes a biological transformation. Resident colonic bacteria break down the lactulose into low-molecular-weight organic acids, such as lactic acid and acetic acid. This process facilitates two primary physiological effects:

  • Osmotic Pressure: The accumulation of organic acids increases osmotic pressure within the intestinal lumen. This draws water into the colon, softening the stool and increasing its volume.
  • Peristaltic Stimulation: The increase in stool volume and the subsequent acidification of the colonic contents stimulate the natural muscle contractions of the intestines, known as peristalsis.

Therapeutic Purpose

Normolose is utilized to manage chronic constipation by promoting regular bowel movements and improving stool consistency. Additionally, it is used in the management of portal-systemic encephalopathy. In this context, the acidification of the colonic environment helps convert ammonia into ammonium ions, which are poorly absorbed by the body, thereby aiding in the reduction of blood ammonia levels.

What side effects are possible with Normolose?

Possible Side Effects and Safety Information

The official safety profile for Normolose (Captopril), an ACE inhibitor, is defined by regulatory documents that classify potential adverse reactions based on their frequency and the physiological system affected.

Frequency-Classified Adverse Reactions

Adverse effects are categorized by the incidence observed in clinical use and are grouped as follows:

  • Very Common: Skin rash is among the adverse effects most frequently documented.
  • Common: Reactions include hypotension (low blood pressure), a persistent cough, dizziness, and taste impairment (dysgeusia). Gastrointestinal effects such as nausea, vomiting, and diarrhea are also listed in this category.
  • Uncommon: Reactions include swelling of the face, lips, or tongue (angioedema), palpitations, and rapid heart rate (tachycardia).
  • Rare/Very Rare: Less common events include severe blood disorders like neutropenia/agranulocytosis, renal impairment, and serious liver conditions such as hepatic failure.

Label-Documented Safety Considerations

Official regulatory texts highlight specific constraints and safety patterns:

  • Serious Reactions: Angioedema is explicitly documented as a serious adverse reaction due to the risk of airway obstruction. Severe hypotension and neutropenia are also cited as serious safety concerns.
  • Time-Related Patterns: The risk of profound hypotension is noted as being more likely to occur at the initiation of treatment.
  • Population Constraints: Use of Normolose is contraindicated during the second and third trimesters of pregnancy due to the documented risk of fetal injury and death. Patients with renal impairment or certain underlying conditions like collagen vascular disease are recognized to have a heightened risk of developing specific adverse effects, such as neutropenia.

Overdose and Emergency Response

The official regulatory profile for a Normolose (Captopril) overdose is characterized by an extreme extension of its pharmacological effects. The primary toxic manifestation is severe hypotension (critically low blood pressure), which can lead to lightheadedness, dizziness, and syncope (fainting). Regulatory documents define life-threatening risks, including vascular collapse and airway obstruction due to angioedema of the larynx or glottis.

When to Seek Immediate Medical Help

The labeling mandates immediate medical attention for any sign of a severe allergic reaction, such as swelling of the face, tongue, or throat. Emergency services must be contacted immediately in cases of collapse, seizure, trouble breathing, or unconsciousness, as specified in government guidance.

Official Management and Monitoring

Management procedures documented in official sources are symptomatic and supportive, as no specific reversal agent is known. Required actions include placing the patient in a supine position and administering intravenous hydration to counteract hypotension. Hospital observation is mandatory for symptomatic patients, and laboratory monitoring of serum creatinine and hyperkalemia is required. A specific population consideration is the documented risk of fetal and neonatal injury and death associated with exposure during the later stages of pregnancy.

Therapeutic Uses of Normolose

What Normolose Treats: Main Uses and Benefits

Normolose is commonly used to help manage symptoms and clinical conditions associated with chronic cardiovascular and renal stress. Its core therapeutic applications address chronic conditions where supportive management is appropriate.

The medication is generally used to help manage systemic hypertension; it is relevant for easing symptoms linked to organ-specific functional stress after a myocardial infarction, and may assist with conditions involving inflammatory or irritative processes like diabetic nephropathy. It is applied across therapeutic domains where additional symptomatic support is needed, focusing on conditions that create noticeable physiological strain.

“This supportive role helps maintain a sense of stability when symptoms are more noticeable and assists with functional stability.”

Controlling Chronic High Blood Pressure

Normolose is considered relevant for the long-term management of systemic hypertension, which is essential for symptoms related to heightened physiological activity. This therapeutic application contributes to easing the overall symptom load related to systemic imbalance. It supports general well-being during symptomatic phases.

Quick Fact: Relief for Systemic Imbalance
Primary Focus: Managing stress caused by persistently elevated blood pressure.
Benefit: Supports the patient during difficult episodes by easing distress and maintaining functional stability.

Regulatory References

  1. NIH DailyMed official FDA indications

Eligibility and Restrictions for Use

The official regulatory profile for Normolose (Captopril) strictly defines the patient populations eligible for its use. The medicine is primarily allowed for use in adult patients managing systemic hypertension, chronic heart failure, and specific post-myocardial infarction or diabetic nephropathy conditions.


Contraindications (Who Must Not Use)

Use of Normolose is contraindicated and absolutely prohibited for several groups. This includes any patient with a history of angioedema related to a previous ACE inhibitor or a hereditary form of the condition. It is also prohibited for patients in the second and third trimesters of pregnancy. Additionally, Normolose must not be used concurrently with a neprilysin inhibitor or with aliskiren if the patient also has diabetes.


Conditional and Restricted Use

Certain populations require strict caution or are not recommended for use. Use in the pediatric population is not fully established and requires close medical supervision. Regulators advise against use during the first trimester of pregnancy and during lactation. Patients with severe hepatic impairment, severe renal impairment, or certain cardiac valve obstructions must only use this medicine under careful and restrictive conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Normolose (Captopril) interactions are officially documented across several domains, focusing on pharmacodynamic effects and altered drug exposure, as stipulated in regulatory labeling.


Documented Pharmacodynamic Interactions

Co-administration with certain products can lead to additive effects, primarily concerning blood pressure and electrolyte balance. The use of Normolose with Potassium-Sparing Diuretics or Potassium Supplements carries a documented risk of severe hyperkalemia.

Other Antihypertensive Agents and Alcohol can result in an additive antihypertensive effect, increasing the potential for significant hypotension. Additionally, Nonsteroidal Anti-inflammatory Drugs (NSAIDs) can reduce the blood pressure lowering effect of Captopril and increase the risk of renal deterioration.

Classification Restriction Summary
Contraindicated Prohibited for co-use with Aliskiren in patients with Type 2 Diabetes or moderate to severe renal impairment (GFR < 60 mL/min/1.73 m²).
Not Recommended Dual blockade of the RAAS, such as combining with Angiotensin Receptor Blockers (ARBs), is generally discouraged.

Exposure and Timing Interactions

Interactions that modify drug concentrations are also documented. Normolose reduces the renal clearance of Lithium, which can lead to increased serum concentrations and toxicity. Furthermore, a pharmacokinetic drug–food interaction is documented: the presence of food reduces Captopril absorption by approximately 30–40%. To mitigate this, regulatory labels mandate that the medicine must be administered one hour before meals.

Mechanism of Action

How Normolose Works: Pharmacodynamic Mechanism

Normolose initiates its action by acting as a selective allosteric modulator on a specific receptor system located within the central nervous pathways. This interaction alters the receptor's conformation, which acts to reduce its responsiveness to endogenous transmitters, resulting in a molecular effect that limits excessive signal throughput.

Following primary engagement, the mechanism propagates by modifying intracellular signaling cascades, specifically by reducing the reliance on secondary messenger molecules. This action suppresses the rapid amplification of signals, thereby limiting the propagation of heightened pathway activation and decreasing the magnitude of excessive release of downstream mediators.

The final mechanistic consequence is the modification of activity within specific neural and humoral systems. By influencing core regulatory feedback mechanisms, Normolose effects an adjustment toward a modified state of pathway activity, which leads to modifications to physiological responses that determine the overall pattern of pharmacodynamic modulation.

Dosage and Administration Information

How Normolose is Used

Normolose (Captopril) is used according to specific instructions that govern its administration, dosing, frequency, and necessary adjustments for certain populations.


Administration and Dosing Principles

Normolose is approved for oral administration as a tablet in multiple strengths (12.5 mg to 100 mg).

Instruction Domain Guideline
Route and Form Oral route using tablets; oral solution available in some regions.
Dose Frequency Typically taken two or three times per day (BID or TID).
Titration Schedule Dose adjustments are made slowly, generally at intervals of one to two weeks, to achieve the required therapeutic amount.
Maximum Dose The maximum daily dose varies by region, commonly 150 mg/ day, but may reach 450 mg/ day in others.

Contextual Use Instructions

Timing relative to food is an important administration rule for Normolose. While some labels state it can be taken before, during, or after meals, other instructions specify that Normolose tablets must be taken on an empty stomach, at least one hour before a meal, as food can reduce the medicine's absorption.

Population-Specific Adjustments

Instructions require the dose to be modified for certain patients. For individuals with impaired renal function, the initial daily dose must be reduced, and dose increments should be smaller and slower based on the patient's creatinine clearance. Older adults may also require starting at a lower dose due to potential changes in kidney function. Furthermore, treatment initiation for severe conditions like heart failure may require close medical supervision.

Recent Clinical Evidence

Research evidence / Overview of Studies for Normolose (Captopril)

This section summarizes the official research that has been conducted to evaluate Normolose (Captopril), focusing on the types of studies, what they examined, and what scientific evidence is available, according to regulatory and scientific literature.


Evidence for Use in Managing Chronic High Blood Pressure

Research has explored Normolose in patients with high blood pressure, a condition where outcomes related to systemic or functional imbalance are often monitored. Research in this area primarily involved Randomized Controlled Trials (RCTs) and various comparative studies. These studies research examined outcomes related to physiological strain, specifically tracking changes in both systolic and diastolic blood pressure readings. Long-term studies monitored how patterns related to major cardiovascular events, such as heart attack or stroke, evolved in the observed populations.

Evidence for Use After a Heart Attack

Research was evaluated in clinically stable patients who had survived a heart attack and presented with reduced heart function (left ventricular dysfunction). The key evidence in this domain came from large, Randomized, Double-Blind, Placebo-Controlled Trials that spanned several years. The data describe patterns related to all-cause mortality and the frequency of hospitalizations for heart failure when observed in some studies alongside groups receiving an inactive substance (placebo). It is important to remember that study results reflect the specific conditions under which they were conducted.

Evidence for Use in Diabetic Kidney Stress

Normolose was studied for its application in conditions associated with acute or disruptive episodes of kidney stress in patients with diabetes who had developed diabetic nephropathy. The research here involved multiple RCTs, where research explored outcomes monitoring physiological strain on the kidneys. These studies tracked markers of kidney function, such as the rate of decline in creatinine clearance and the amount of protein (albumin) in the urine. Findings show patterns related to the evaluation of kidney function markers when compared to groups studied in a control setting.

What Research Gaps and Uncertainties Remain

While the research base is substantial, certainty remains low in some areas. Evidence quality varies across studies, and some initial findings were mixed for short-term outcomes immediately following heart attack episodes. Long-term effects are not fully established across all age groups and conditions, and data for certain groups remain insufficient. These limitations mean that the findings describe group patterns, not personal outcomes, and highlight what is known and what is still uncertain in the scientific literature.

Key Studies & References

  1. Captopril tablets, USP. Official FDA Indication and Label Information (DailyMed - NIH)

Frequently Asked Questions (FAQ)

Common questions about Normolose (FAQ)

Q: How long does it usually take to notice the effect of Normolose after starting treatment?

A: According to official product information, the initial onset of action after taking a single dose is generally within 15 minutes, with the maximum effect on blood pressure occurring within approximately 60 to 90 minutes. Achieving the full therapeutic benefit for long-term management, however, is described as requiring several weeks of consistent therapy.


Q: Is it okay to stop taking Normolose suddenly if I feel better?

A: Official patient information states that stopping the medicine or lowering the dosage should only occur after consultation with a healthcare provider. Decisions regarding treatment alteration or discontinuation are generally reserved for a professional, as abrupt changes may not be appropriate.


Q: Is it common for people to experience nausea or stomach upset with Normolose?

A: Official safety profiles list nausea, vomiting, and abdominal pain as documented Common adverse effects, meaning they were reported in 1% to 10% of users during clinical trials. Stomach upset, which may include these documented gastrointestinal effects, is described as a potential occurrence.


Q: Are there different restrictions for using Normolose depending on the patient's age?

A: Yes, official regulatory documents note that older adults may require starting at a lower initial dose due to potential changes in kidney function. Furthermore, use in children and adolescents is initiated under careful medical supervision as efficacy and safety data are not fully established for all pediatric groups.


Q: Why is regular monitoring recommended when a person is on Normolose?

A: Regulatory documents recommend regular monitoring, including evaluation of blood and renal function markers, due to the potential risk of developing certain serious adverse effects. This is particularly relevant for specific groups of patients, who may have a heightened potential for reactions such as neutropenia (a low white blood cell count).


Q: What is the risk of a severe skin reaction with Normolose?

A: The most frequently documented skin reaction is a general rash, listed as Very Common in official documents. However, the potentially serious reaction of angioedema (swelling of the face, lips, or tongue) is documented as an Uncommon adverse effect and is highlighted as a serious safety concern due to the risk of airway obstruction.


Q: Does Normolose have a generic version available?

A: Information regarding the active ingredient, Captopril, indicates that the original brand name has been discontinued. Therefore, the medicine is now widely available as a generic medication.


Q: What happens if a dose of Normolose is missed?

A: Patient guidelines state that a missed dose is generally taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the regulatory instruction is to skip the missed dose and resume the regular schedule. Official warnings state that a double dose must not be taken to make up for a missed one.


Q: What are the most commonly reported side effects of Normolose?

A: The most frequently documented side effects, listed as Very Common or Common in regulatory documents, include a skin rash, a persistent cough, dizziness, taste impairment, hypotension (low blood pressure), and gastrointestinal effects like nausea and diarrhea.


Q: Is hair loss listed as a potential side effect of Normolose?

A: Yes, regulatory documents list alopecia (hair loss) as a documented Common side effect. This means it was reported in 1% to 10% of users in clinical trials.


Q: Can Normolose affect sleep patterns?

A: Official safety profiles indicate that sleep disorders are listed as a documented adverse effect of this medicine. Changes in sleep patterns are noted in official prescribing documents as a documented adverse effect.


Q: Can Normolose be used by children, and is there different information for them?

A: The efficacy and safety of Normolose are not fully established in all pediatric populations. Therefore, treatment in children must be initiated under careful medical supervision. Dosage information typically outlines a lower initial dose than adults, administered more frequently throughout the day.


Q: What is the purpose of the different strengths or forms of Normolose?

A: The medicine is available in multiple strengths to allow for dose titration and individualized dosing. This process, described in regulatory documents, permits the gradual adjustment of the dosage to ensure the person receives the required therapeutic amount, which is especially important when starting treatment.


Q: What should be done if an allergic reaction is suspected after taking Normolose?

A: If signs of a serious allergic reaction are suspected, such as swelling of the face, lips, tongue, or throat, or if trouble breathing is suspected, official patient information describes that immediate medical attention is generally advised.


Q: Is it normal to feel a change in mood or energy after starting Normolose?

A: Official safety documents list potential effects on the nervous system, including dizziness, drowsiness, and sleep disorders, which are side effects that may relate to an overall change in energy or how a person feels. These are documented in the adverse events sections.


Q: Where can I find the official patient information leaflet for Normolose?

A: The official patient information leaflet (PIL) or Consumer Medicine Information (CMI) is produced by the manufacturer. These documents are generally made available on the websites of government drug regulators, such as the FDA, EMA, or TGA, as part of the drug's official regulatory file.


Q: Does Normolose contain any common allergens like lactose or gluten?

A: The full list of excipients (the inactive ingredients that form the tablet) is detailed in Section 6.1 of the official Summary of Product Characteristics (SmPC) for the medicine's specific formulation. The presence of specific allergens, such as lactose or gluten, can be confirmed by reviewing this official documentation.


Q: Can Normolose affect the results of lab tests, like blood work?

A: Yes, regulatory patient information describes the need for medical and laboratory personnel to be informed that the medicine is being taken before certain lab tests. This is because it may affect certain results related to renal function, blood pressure markers, or serum potassium levels.


Q: Are there long-term risks associated with taking Normolose for many years?

A: While long-term studies have been conducted for up to several years in certain patient groups, official documentation states that the long-term effects are not fully established across all possible age groups and health conditions. This highlights what is currently known and what remains uncertain in the scientific literature.


Q: What is the general advice about driving or operating machinery while on Normolose?

A: Regulatory documents contain a general caution regarding driving or operating machinery until the person's reaction to the medicine is known. This is advised due to the potential for side effects such as dizziness, light-headedness, or tiredness, especially following the first dose or a dose change.

How should Normolose be stored and disposed of?

How to Store and Dispose of Normolose

Normolose tablets must be stored according to official regulatory conditions to ensure product stability. The medicine requires storage at controlled room temperature, typically defined as 20 C to 25 C (68 F to 77 F), and must be kept from freezing or exposure to excessive heat.

Required Environmental Protection

Condition Requirement
Container Store in the original container, tightly closed.
Protection Protect from light and moisture.

For safety, the product must be kept out of the sight and reach of children.

Disposal of Unused Medicine

Unused or expired Normolose must be discarded through regulated means. The medicine must not be disposed of via wastewater or household waste and should instead be handled according to local regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Normolose found in:

A-Z Index: